Disappointing sales were blamed on prior authorization, the FDA label restrictions, and the need for spirometry before doctors could write prescriptions.
Andrew Smith, AJMC
Advertisement
Articles by Andrew Smith, AJMC
Advertisement
Latest Updated Articles
Future of Sanofi's Inhalable Insulin in DoubtPublished: January 8th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Addressing Drug Resistance in Lung Cancer
2
From Mutation to Medicine: Targeted Therapies in Lung Cancer
3
Abemaciclib Provides Long-Term Survival Benefit in High-Risk Early Breast Cancer
4
TAR-200 Intravesical System Demonstrates Sustained Bladder Exposure in BCG-Unresponsive NMIBC
5
